Lakeshore Capital Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Lakeshore Capital Group's LLY Position: Q3 2026 in Review
Lakeshore Capital Group increased its Eli Lilly (LLY) stake by 4.9% in Q3 2026, buying an estimated $60.2K and bringing the position to 1,097 shares worth $1.27M. The position accounts for 0.81% of the portfolio, ranked #36.
Lakeshore Capital Group first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. 4,616 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Lakeshore Capital Group held 1,097 shares of Eli Lilly worth $1.27M as of Q3 2026.
- Lakeshore Capital Group bought 51 Eli Lilly shares in Q3 2026, an estimated $60.2K.
- Eli Lilly made up 0.81% of Lakeshore Capital Group's portfolio in Q3 2026, its #36 holding.
- Lakeshore Capital Group first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
- 4,616 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Lakeshore Capital Group's 13F filing for Q3 2026, filed 20 Oct 2026.